Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Treatments for hair loss include hormone modifiers, minoxidil, and hair transplant surgery.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

New treatments for skin diseases are more effective and patient-friendly, but many still lack a cure.

PCOS is a common hormonal disorder in women that can lead to various health issues and requires comprehensive management.

Non-invasive imaging helped diagnose a woman's severe hormone imbalance and diabetes, and medication successfully treated her condition.

Hormone treatment caused hair loss, finasteride helped regrowth.

Hair growth environment recreated with challenges; stem cells make successful skin organoids.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

Longer hair loss leads to more severe CCCA; early treatment and avoiding damaging hairstyles help regrowth.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Early diagnosis and treatment of PCOS in teenagers can help prevent more severe adult PCOS.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Angiogenin helps hair grow by stimulating cell growth and blood vessel formation.